Show simple item record

dc.contributor.authorYeoh, J.
dc.contributor.authorYudi, M.
dc.contributor.authorAndrianopoulos, N.
dc.contributor.authorYan, B.
dc.contributor.authorClark, D.
dc.contributor.authorDuffy, S.
dc.contributor.authorBrennan, A.
dc.contributor.authorNew, G.
dc.contributor.authorFreeman, M.
dc.contributor.authorEccleston, D.
dc.contributor.authorSebastian, M.
dc.contributor.authorReid, Christopher
dc.contributor.authorWilson, W.
dc.contributor.authorAjani, A.
dc.identifier.citationYeoh, J. and Yudi, M. and Andrianopoulos, N. and Yan, B. and Clark, D. and Duffy, S. and Brennan, A. et al. 2017. Evolution of Australian Percutaneous Coronary Intervention (from the Melbourne Interventional Group [MIG] Registry). American Journal of Cardiology. 120 (1): pp. 47-54.

Percutaneous coronary intervention (PCI) continues to evolve with shifting patient demographics, treatments, and outcomes. We sought to document the specific changes observed over a 9-year period in a contemporary Australian PCI cohort. The Melbourne Interventional Group is an established multicenter PCI registry in Melbourne, Australia. Data were collected prospectively with 30-day and 12-month follow-ups. Demographic, procedural, and outcome data for all consecutive patients were analyzed with a year-to-year comparison from 2005 to 2013. National Death Index linkage was performed for long-term mortality analysis; 19,858 procedures were captured over 9 years. Patient complexity and acuity increased with a higher proportion of traditional risk factors and more elderly patients who underwent PCI. Angiographic lesion complexity increased with more multivessel coronary artery disease and more American College of Cardiology/American Heart Association type B2/C lesions proceeding to PCI. The 30-day rate of death, myocardial infarction, or target vessel revascularization has not changed nor has 12-month mortality, myocardial infarction, or major adverse cardiovascular event rates. The strongest independent predictor of long-term mortality was cardiogenic shock at presentation (hazard ratio [HR] 2.95, p <0.01). Drug-eluting stent use (HR 0.83, p <0.01) and a history of dyslipidemia (HR 0.81, p <0.01) were associated with long-term survival. In conclusion, from 2005 to 2013, we observed a cohort of higher risk clinical and angiographic characteristics, with stable long-term mortality.

dc.publisherExcerpta Medica, Inc
dc.titleEvolution of Australian Percutaneous Coronary Intervention (from the Melbourne Interventional Group [MIG] Registry)
dc.typeJournal Article
dcterms.source.titleAmerican Journal of Cardiology
curtin.departmentDepartment of Health Policy and Management
curtin.accessStatusFulltext not available

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record